X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (39) 39
psychiatry (38) 38
male (34) 34
female (30) 30
adult (28) 28
schizophrenia (27) 27
middle aged (19) 19
pharmacology & pharmacy (18) 18
young adult (17) 17
neurosciences (16) 16
retrospective studies (15) 15
analysis (14) 14
adolescent (11) 11
clinical neurology (11) 11
clozapine (11) 11
animals (10) 10
psychiatric services (10) 10
antidepressants (9) 9
bipolar disorder (9) 9
cohort studies (9) 9
depression (9) 9
israel (9) 9
antipsychotic agents - therapeutic use (8) 8
treatment-resistant schizophrenia (8) 8
aged (7) 7
antidotes - therapeutic use (7) 7
comorbidity (7) 7
medicine, general & internal (7) 7
metaanalysis (7) 7
mortality (7) 7
poisoning (7) 7
risk factors (7) 7
antidepressive agents - therapeutic use (6) 6
chemical warfare (6) 6
health aspects (6) 6
risk (6) 6
schizophrenia - drug therapy (6) 6
usage (6) 6
aged, 80 and over (5) 5
antipsychotic agents - adverse effects (5) 5
antipsychotics (5) 5
anxiety (5) 5
chemical terrorism (5) 5
child (5) 5
clozapine - adverse effects (5) 5
follow-up studies (5) 5
mania (5) 5
medical research (5) 5
medicine, experimental (5) 5
nerve agents (5) 5
organophosphates (5) 5
psychiatric status rating scales (5) 5
psychosis (5) 5
rats (5) 5
time factors (5) 5
toxicology (5) 5
treatment-resistant (5) 5
adherence (4) 4
adults (4) 4
antidepressants, tricyclic (4) 4
antipsychotic drugs (4) 4
atypical antipsychotics (4) 4
brain (4) 4
case-control studies (4) 4
clozapine - therapeutic use (4) 4
cognition (4) 4
depression, mental (4) 4
disorders (4) 4
exposure (4) 4
hospitalization (4) 4
hospitalization - statistics & numerical data (4) 4
israel - epidemiology (4) 4
medicine and health sciences (4) 4
metabolic syndrome (4) 4
multivariate analysis (4) 4
paraoxon (4) 4
paraoxon - toxicity (4) 4
patient compliance (4) 4
patient outcomes (4) 4
patients (4) 4
prevention (4) 4
prospective studies (4) 4
psychiatry and psychology (4) 4
rats, sprague-dawley (4) 4
toxicity (4) 4
adolescents (3) 3
adverse events (3) 3
age factors (3) 3
algorithms (3) 3
alzheimers-disease (3) 3
bipolar disorder - epidemiology (3) 3
bipolar disorder - psychology (3) 3
brain damage (3) 3
cancer (3) 3
care and treatment (3) 3
catie schizophrenia (3) 3
chemical warfare agents - poisoning (3) 3
chemical warfare agents - toxicity (3) 3
children (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Nervous and Mental Disease, ISSN 0022-3018, 09/2019, Volume 207, Issue 9, pp. 721 - 725
ABSTRACTClustering of symptoms to characterize simple schizophrenia is still debated, and support is needed for the characterization of simple schizophrenia as... 
Psychosis | negative | deteriorative disorder | PSYCHIATRY | deficit syndrome | clozapine | RISPERIDONE | CLINICAL NEUROLOGY
Journal Article
EBioMedicine, ISSN 2352-3964, 12/2017, Volume 26, Issue C, pp. 138 - 145
Journal Article
Schizophrenia Bulletin, ISSN 0586-7614, 04/2019, Volume 45, Issue Supplement_2, pp. S297 - S297
Abstract Background About a third of schizophrenia patients would not have sufficient clinical response to antipsychotic treatment. The only drug approved for... 
Journal Article
Schizophrenia Bulletin, ISSN 0586-7614, 04/2019, Volume 45, Issue Supplement_2, pp. S310 - S310
Abstract Background Low levels of vitamin D are prevalent among patients with schizophrenia and previously had been linked to the risk and outcome of the... 
Journal Article
Schizophrenia Bulletin, ISSN 0586-7614, 04/2018, Volume 44, Issue suppl_1, pp. S339 - S340
Abstract Background Vitamin D deficiency is highly prevalent in patients with psychosis. While accumulating data suggests that vitamin D deficiency may be... 
Abstracts
Journal Article
Depression and Anxiety, ISSN 1091-4269, 10/2019, Volume 36, Issue 10, pp. 921 - 929
Background: Depression and anxiety are common in cancer and antidepressants (AD) are efficacious treatment. The relationship between AD adherence and mortality... 
mortality | antidepressants | cancer | Cancer patients | Patient outcomes | Analysis | Oncology, Experimental | Mortality | Depression, Mental | Melanoma | Research | Prostate cancer | Patient compliance | Cancer | Antidepressants, Tricyclic | Socio-economic aspects | Mental depression | Patients | Antidepressants | Breast | Anxiety | Colon | Health risk assessment | Prostate | Smoking
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 10/2018, Volume 38, Issue 5, pp. 520 - 527
Journal Article
Psychiatry Research, ISSN 0165-1781, 05/2019, Volume 275, pp. 155 - 161
Clozapine is the most effective treatment for refractory schizophrenia, yet it remains underused in clinical practice. The current study examined the... 
Attitudes | Antipsychotics | Treatment-resistant schizophrenia | Clozapine | Knowledge | Surveys | Usage | Medical examination | Psychiatrists | Schizophrenia | Drug therapy | Patient compliance | Blood
Journal Article
FRONTIERS IN PSYCHIATRY, ISSN 1664-0640, 05/2019, Volume 10, p. 288
Classifying patients' affect is a pivotal part of the mental status examination. However, this common practice is often widely inconsistent between raters.... 
MOOD | PSYCHIATRY | affect | face recognition | clinical psychiatry | CLINICIAN | schizophrenia | FUTURE | machine learning | Usage | Affect (Psychology) | Machine learning | Schizophrenia | Diagnosis | Identification and classification | Facial expression
Journal Article
Journal Article